Table 6.
Histologically verified high-grade lesions (n, % of total) among screening test positivea women by mode of follow-up.
| Women screened by self-sampling and triaged by gynaecologistb | Women screened by self-sampling and triaged by GPc | Women screened by clinician (any arm) or triaged outside studyd | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total positive | 16/18 positivee | Other HR positivef | Total positive | 16/18 positivee | Other HR positivef | Total positiveg | 16/18 positivee | Other HR positivef | Cytology positiveh | |
| Total | 31 (100.0) | 14 (100.0) | 17 (100.0) | 32 (100.0) | 9 (100.0) | 23 (100.0) | 34 (100.0) | 13 (100.0) | 17 (100.0) | 2 (100.0) |
| Had histology resulti | 26 (83.9) | 14 (100.0) | 12 (70.6) | 13 (40.6) | 5 (55.6) | 8 (34.8) | 21 (61.8) | 10 (76.9) | 7 (41.2) | 2 (100.0) |
| CIN2 + detectedj | 10 (32.3) | 9 (64.3) | 1 (5.9) | 11 (34.4) | 5 (55.6) | 6 (26.1) | 12 (35.3) | 9 (69.2) | 1 (5.9) | 2 (100.0) |
| CIN3 + detectedk | 9 (29.0) | 8 (57.1) | 1 (5.9) | 10 (31.3) | 5 (55.6) | 5 (21.7) | 12 (35.3) | 9 (69.2) | 1 (5.9) | 2 (100.0) |
| Cervical cancer detected | 4 (12.9) | 4 (28.6) | 0 (0.0) | 4 (12.5) | 3 (33.3) | 1 (4.3) | 3 (8.8) | 3 (23.1) | 0 (0.0) | 0 (0.0) |
aPositive HPV test, or ASCUS + for cytology.
bWomen from any self-sampling arm who were allocated to and attended gynaecologist triage.
cWomen from any self-sampling arm who were allocated to and attended GP triage.
dWomen from any intervention arm who were screened by a clinician, and women from any self-sampling arm who self-sampled but attended triage outside the study.
ePositive for HPV16 and/or 18, and may be positive for other high-risk HPV types.
fPositive for any of the high-risk HPV types 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 or 68, but not positive for 16/18.
gTwo women were registered as hrHPV-positive, but lacked information on hrHPV-type.
hDid not have HPV screening test.
iRegistered with a histology diagnosis in the CervicalScreen Norway/CRN databases.
jCIN2, CIN3, ACIS or cancer.
kCIN3, ACIS or cancer.